IP Library › Granted Patent US 9,026,188
Granted Patent B2
US 9,026,188 · App. 12/867,199 · Granted May 5, 2015

Measurement apparatus and method therefor

Inventors: Robin Taylor (Berkshire, GB); Richard Holley (Berkshire, GB); Austen Hearn (Reading, GB)
Assignee: Lein Applied Diagnostics
A61B5/1455A61B3/1005A61B5/14532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,026,188
App. No.
12/867,199
Granted
May 5, 2015
Kind
B2
Abstract

A measurement apparatus comprises a probe system ( 100 ) operably coupled, when in use, to a processing resource ( 134 ). The probe system ( 100 ) and the processing resource ( 134 ) are arranged, when in use, to measure an apparent thickness change of a volume of the medium ( 108 ) to be measured and to determine a physiological parameter using the measurement of the apparent thickness change.

Claims (29)

1. A measurement apparatus comprising:

a probe system operably coupled, when in use, to a processing resource;

the probe system and the processing resource are arranged, when in use, to measure an apparent thickness of a volume of corneal tissue referenced at a time, and determine an apparent thickness change thereof in respect of the referenced time;

a storage device arranged to record a correlation or regression between the apparent thickness change of the volume of the corneal tissue and a blood-glucose concentration level;

wherein the processing resource is arranged to access the storage device and to use the measurement of apparent thickness change to determine the blood-glucose concentration level in respect of the referenced time from the correlation or regression accessed;

the probe system comprises a source arranged to emit, when in use, a probe beam and a scanning lens and/or waveguide, wherein the probe system scans the corneal tissue to determine the apparent thickness change thereof.

2. An apparatus as claimed in claim 1 , wherein the probe system is an optical system.

3. An apparatus as claimed in claim 1 , wherein the apparent thickness change of the volume of the corneal tissue is in respect of a target portion of the corneal tissue.

4. An apparatus as claimed in claim 1 , wherein the apparent thickness is between a first surface and a second surface of the corneal tissue.

5. An apparatus as claimed in claim 1 , wherein the probe system is arranged to generate a trace in response to electromagnetic radiation received thereby, and the processing resource is arranged to identify a first localised maximum in the trace and a second localised maximum in the trace.

6. An apparatus as claimed in claim 5 , wherein the processing resource is arranged to locate the first localised maximum by fitting a first curve thereto and/or the processing resource is arranged to locate the second localised maximum by fitting a second curve thereto.

7. An apparatus as claimed in claim 1 , wherein the processing resource is arranged to calculate the apparent thickness change of the volume of the corneal tissue over time.

8. An apparatus as claimed in claim 1 , wherein the probe system is arranged to determine a first apparent thickness in respect of the volume of the corneal tissue at a first point in time and a second apparent thickness in respect of the volume of the corneal tissue at a second point in time; and the processing resource is arranged to calculate an integral of the apparent thickness of the volume of the corneal tissue between the first and second points in time.

9. An apparatus as claimed in claim 1 , further comprising a data store for recording calibration data, the processing resource being arranged to use the calibration data to compensate for patient-specific corneal thickness when determining the blood-glucose concentration level.

10. An apparatus as claimed in claim 1 , wherein the probe system and the processing resource are arranged to use multiple sites on the volume of the corneal tissue to determine the changes in apparent thickness of the volume of the corneal tissue.

11. An apparatus as claimed in claim 10 , wherein the probe system is arranged to determine a first apparent thickness in respect of the volume of the corneal tissue at a first point in time and a second apparent thickness in respect of the volume of the corneal tissue at a second point in time; and the multiple sites are employed to generate the first apparent thickness at the first point in time and the same multiple sites are respectively employed to generate the second apparent thickness at the second point in time.

12. An apparatus as claimed in claim 1 , wherein the processing resource is arranged to provide an expected apparent thickness of the volume of the corneal tissue at a time of measurement.

13. An apparatus as claimed in claim 12 , wherein the processing resource is arranged to employ a function to calculate the change in apparent thickness of the volume of the corneal tissue associated with the blood-glucose concentration level using the expected apparent thickness and a measurement of the apparent thickness of the volume of the corneal tissue.

14. An apparatus as claimed in claim 13 , wherein the function is a difference calculation between the expected apparent thickness and the measured apparent thickness.

15. An apparatus as claimed in claim 12 , wherein the expected apparent thickness is obtained from a change in apparent thickness of the volume of the corneal tissue over time.

16. An apparatus as claimed in claim 12 , wherein the expected apparent thickness is obtained from a data set derived from empirical data of change in apparent thickness of the volume of the corneal tissue over time.

17. An optical measurement apparatus or a glucometer comprising the measurement apparatus as claimed in claim 1 .

18. A method of measuring a property of a corneal tissue, comprising;

probing a volume of the corneal tissue in order to receive a feedback signal;

measuring an apparent thickness of the volume of the corneal tissue referenced at a time using the feedback signal;

determining an apparent thickness change of the volume of the corneal tissue in respect of the referenced time;

accessing a record of a correlation or regression between the apparent thickness change of the volume of the corneal tissue and a blood-glucose concentration level;

using the measurement of apparent thickness change to determine the blood-glucose concentration level in respect of the referenced time from the correlation or regression accessed and

wherein the probing comprises scanning the corneal tissue with a probe system comprising a source arranged to emit, when in use, a probe beam and a scanning lens and/or waveguide to determine the apparent thickness change thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2022
From: COMMI HOLDINGS LIMITED
To: OCCUITY LIMITED
Reel/Frame 060805/0121 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2020
From: LEIN APPLIED DIAGNOSTICS LIMITED
To: COMMI HOLDINGS LIMITED
Reel/Frame 053435/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2010
From: TAYLOR, ROBIN; HOLLEY, RICHARD; HEARN, AUSTEN
To: LEIN APPLIED DIAGNOSTICS
Reel/Frame 025317/0001 →
Priority Claims (1)
GB 0802480.4 · Feb 11, 2008 · national
Continuity (1)
Related Publication 20120179380A1 · Jul 12, 2012